ArticleScientific reports2023

JT002, a small molecule inhibitor of the NLRP3 inflammasome for the treatment of autoinflammatory disorders.

Geza Ambrus-Aikelin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.